Bjornsdottir, Hulda Hrund
Rawshani, Araz
Rawshani, Aidin
Franzén, Stefan
Svensson, Ann-Marie
Sattar, Naveed http://orcid.org/0000-0002-1604-2593
Gudbjörnsdottir, Soffia
Funding for this research was provided by:
European Foundation for the Study of Diabetes
Swedish Association of Local Authorities and Regions
Article History
Received: 30 January 2020
Accepted: 14 September 2020
First Online: 15 October 2020
Competing interests
: ArR has received personal fees from Novo Nordisk. NS has consulted for Amgen, AstraZeneca, Boehringer Ingelheim, Eli Lilly, Janssen, Napp Pharmaceuticals, Novo Nordisk, Pfizer and Sanofi, and received grant support from Boehringer Ingelheim outside the submitted work. SG has received personal fees (lecture fees and research grants) from AstraZeneca, Boehringer Ingelheim, Eli Lilly, Merck Sharp & Dohme, Novo Nordisk, and Sanofi outside of the submitted work. All other authors declare no competing interests.